Most synthetic cannabinoids are agonists with the cannabinoid receptors. They have already been meant to be much like THC,[nine] the organic cannabinoid with the strongest binding affinity for the CB1 receptor, which happens to be linked to the psychoactive outcomes or "superior" of cannabis.[10] These artificial analogs frequently have increased b